Goodrx Holdings Inc
NASDAQ:GDRX
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4.66
9.05
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one GDRX stock under the Base Case scenario is 12.07 USD. Compared to the current market price of 4.66 USD, Goodrx Holdings Inc is Undervalued by 61%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Goodrx Holdings Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for GDRX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Goodrx Holdings Inc
Balance Sheet Decomposition
Goodrx Holdings Inc
Current Assets | 626.8m |
Cash & Short-Term Investments | 423.8m |
Receivables | 159.6m |
Other Current Assets | 43.4m |
Non-Current Assets | 728m |
Long-Term Investments | 15m |
PP&E | 42.5m |
Intangibles | 584.7m |
Other Non-Current Assets | 85.9m |
Current Liabilities | 114.4m |
Accounts Payable | 12.4m |
Accrued Liabilities | 91.9m |
Other Current Liabilities | 10.1m |
Non-Current Liabilities | 544.1m |
Long-Term Debt | 487.6m |
Other Non-Current Liabilities | 56.5m |
Earnings Waterfall
Goodrx Holdings Inc
Revenue
|
790.4m
USD
|
Cost of Revenue
|
-51.2m
USD
|
Gross Profit
|
739.2m
USD
|
Operating Expenses
|
-709.6m
USD
|
Operating Income
|
29.6m
USD
|
Other Expenses
|
-45.8m
USD
|
Net Income
|
-16.2m
USD
|
Free Cash Flow Analysis
Goodrx Holdings Inc
USD | |
Free Cash Flow | USD |
GDRX Profitability Score
Profitability Due Diligence
Goodrx Holdings Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Goodrx Holdings Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
GDRX Solvency Score
Solvency Due Diligence
Goodrx Holdings Inc's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Score
Goodrx Holdings Inc's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GDRX Price Targets Summary
Goodrx Holdings Inc
According to Wall Street analysts, the average 1-year price target for GDRX is 9.63 USD with a low forecast of 5.05 USD and a high forecast of 16.8 USD.
Dividends
Current shareholder yield for GDRX is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
GoodRx Holdings, Inc. operates a consumer-focused digital healthcare platform. The company is headquartered in Santa Monica, California and currently employs 756 full-time employees. The company went IPO on 2020-09-23. The firm provides GoodRx platform, which aggregates and analyzes pricing data from a number of different sources. Its platform also provides access to medication savings programs, medical provider consultations and lab tests through its telehealth offerings, GoodRx Care and the GoodRx Telehealth Marketplace, and other healthcare related content. Its prescription offering provides price comparisons and negotiated prices on prescriptions. Its subscription offerings provide consumers and their families with access to lower prescription prices on select medications in select pharmacies for a monthly or annual subscription fee. Its pharmaceutical manufacturer solutions offering provides advertising and integrated consumer affordability solutions to pharmaceutical manufacturers.
Contact
IPO
Employees
Officers
The intrinsic value of one GDRX stock under the Base Case scenario is 12.07 USD.
Compared to the current market price of 4.66 USD, Goodrx Holdings Inc is Undervalued by 61%.